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Key questions
What is already known?
 Ź Operational research (OR) has been widely used 
to aid decision makers in low- income and middle- 
income countries (LMICs) to prioritise health 
interventions.
 Ź There is a growing and disproportionate burden of 
non- communicable disease (NCD) on LMICs, and 
on the most vulnerable populations within these 
countries.
 Ź The Sustainable Development Goals (SDGs) empha-
sised the need for interventions which target NCDs 
while simultaneously promoting equity.
What are the new indings?
 Ź The 149 papers included in this review demonstrat-
ed that OR methods are being used to provide valu-
able evidence across a wide range of NCD disease 
burdens and policy options in the SDG era.
 Ź The number of papers were not proportional to the 
LMIC disease burden attributable to each NCD.
 Ź OR in the SDG era demonstrates a strong concern for 
equity, although this was often limited to a focus on 
disadvantaged groups or universal coverage without 
robust consideration of differential impact.
What do the new indings imply?
 Ź OR methods continue to provide valuable evidence 
across a broad range of policy options and NCD dis-
ease burdens in LMICs.
 Ź In future, operational researchers should consider 
including the differential impact of the policies they 
are evaluating, thereby ensuring that equity remains 
a central concern.
AbsTrACT
Introduction Non- communicable diseases (NCDs) 
represent a growing health burden in low- income and 
middle- income countries (LMICs). Operational research 
(OR) has been used globally to support the design of 
effective and eficient public policies. Equity is emphasised 
in the Sustainable Development Goal (SDG) framework 
introduced in 2015 and can be analysed within OR studies.
Methods We systematically searched MEDLINE, Embase, 
Scopus and Web of Science for studies published between 
2015 and 2018 at the intersection of ive domains (OR, 
LMICs, NCDs, health and decision- making and/or policy- 
making). We categorised the type of policy intervention 
and described any concern for equity, which we deined as 
either analysis of differential impact by subgroups or, policy 
focus on disadvantaged groups or promoting universal 
health coverage (UHC).
results A total of 149 papers met the inclusion criteria. 
The papers covered a number of policy types and a broad 
range of NCDs, although not in proportion to their relative 
disease burden. A concern for equity was demonstrated 
by 88 of the 149 papers (59%), with 8 (5%) demonstrating 
differential impact, 47 (32%) targeting disadvantaged 
groups, and 68 (46%) promoting UHC.
Conclusion Overall, OR for NCD health policy in the 
SDG era is being applied to a diverse set of interventions 
and conditions across LMICs and researchers appear to 
be concerned with equity. However, the current focus of 
published research does not fully relect population needs 
and the analysis of differential impact within populations 
is rare.
InTroduCTIon
Non- communicable diseases (NCDs) account 
for 73% of global deaths and 62% of global 
disease burden in 2017, increasing from 
48% to 62% respectively in 2000.1 This rising 
burden has meant that the prevention and 
control of NCDs is now a major global health 
priority. Low- income and middle- income 
countries (LMICs) suffer the majority of 
global NCD- related mortality and morbidity: 
in 2016, an estimated 78% of global NCD- 
related deaths, and 82% of morbidity, 
occurred in LMICs.2 3 Moreover, the NCD 
burden is expected to further increase in 
LMICs as they continue through the epide-
miological transition with its emergence of 
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chronic health issues and NCDs,4 driven in part by urban-
isation, and increasing levels of behavioural risk factors 
such as smoking, physical inactivity and nutritionally 
poor diets5 6 as well as an ageing population. As NCDs 
disproportionately affect working- age adults, increasing 
NCD burden has significant implications for the socioec-
onomic development of these countries.7
Despite these growing challenges, there are a wide range 
of interventions available to policymakers and healthcare 
practitioners to reduce the burden of NCDs in LMICs. An 
effective ‘package’ of measures may encompass diverse 
approaches including: fiscal policies and regulations to 
reduce the key modifiable risk factors such as tobacco 
use and unhealthy diets; population- wide screening 
to achieve early diagnosis and treatment of NCDs and 
access to effective and affordable individual- level health-
care interventions.7 8 However, LMIC governments face 
unique challenges in financing and implementing many 
of these solutions. Their healthcare systems often have 
weak infrastructure for the management of chronic 
conditions associated with NCDs.9 Public policies effec-
tive in reducing risk factors for NCDs elsewhere may 
require adaptations to suit local contexts or risk being 
patchily implemented and poorly enforced.10–13 More-
over, despite improvements in population health insur-
ance coverage in certain LMICs, the service coverage and 
the level of financial protection provided by the insur-
ance are often limited.14
The discipline of operational research (OR) can 
provide quantitative evidence to guide scale- up of inter-
ventions for NCDs15 by projecting the cost, health and 
resource implications of strategies that aim to compare 
interventions, improve healthcare delivery and which may 
improve health/healthcare equity within the constraints 
of the relevant settings.16 17 OR models can synthesise 
diverse evidence types, including context- relevant epide-
miological and economic data, to compare multiple 
strategies affecting different system components, and 
extrapolate natural disease history and intervention 
effects to estimate long- term impact.18 OR methods can 
also account for capacity constraints in existing policy 
and healthcare infrastructure, making them well- suited 
to the evaluation of intervention delivery in low- resource 
contexts.19
A key characteristic of NCDs is their strong link with 
health (in)equity in LMIC contexts. NCDs are important 
contributors to (within- country) health inequity insofar 
as modifiable risk factors for NCDs are typically concen-
trated in population subgroups who have low socioeco-
nomic status (SES) and/or live in poor or marginalised 
communities.20 The weak financial protection offered by 
health insurance schemes in LMICs means that NCDs 
often result in catastrophically high out- of- pocket (OOP) 
expenditures for already impoverished and marginalised 
groups.21 22 Therefore, OR may demonstrate an equity 
focus through: (i) consideration of differential impact 
by socially determined subgroups; (ii) the deliberate 
targeting of policies towards vulnerable groups and/
or (iii) policies which extend access to healthcare (eg, 
universal provision) thus improving financial protection.
Previous reviews include Bradley et al,17 who provided 
an overview of 44 OR studies in LMICs (a subset of 1099 
studies overall) published by 2014, covering both commu-
nicable diseases and NCDs and equity considerations. 
They found health equity consideration was primarily 
manifested in a concern for healthcare equity, particularly 
in relation to hard- to- reach or disadvantaged subgroups. 
For OR to have impact, they recommended researchers 
embed stakeholder engagement, use contextually appro-
priate data and vary communication channels for outputs. 
An earlier, 2006, review by Mulligan et al23 concentrated 
on economic evaluations of NCD interventions in LMICs. 
They classified the 32 included studies by 12 disease areas 
and 3 application areas (diagnosis, prevention and treat-
ment) and assessed their methodological quality.
The 2015 Sustainable Development Goals (SDGs) 
include good health and well- being (SDG 3) and empha-
sise equity throughout. Given these goals, and the partic-
ular challenges posed by NCDs in LMICs, we investigated 
the use of OR in informing NCD- related health policy 
in LMICs, and whether a concern for equity informed 
the analyses. Here, we present results of a scoping review 
of studies published in peer- reviewed journals during 
the SDG era, from January 2015 to May 2018, which 
apply quantitative OR methods to evaluate policies for 
NCD prevention and treatment in LMICs. We provide a 
narrative summary by key themes, including geograph-
ical setting, policy/intervention type and disease area, 
with attention to if/how OR methods have been used to 
support a concern for equity.
MeTHods
This scoping review follows a systematic search strategy and 
analysis to provide a broad overview of the size and scope 
of the literature. A scoping review can provide a prelim-
inary assessment of the literature without the require-
ment of formal quality appraisals required by systematic 
literature reviews for the synthesis of evidence.24 25 This 
approach is able to accommodate both diverse study 
designs and broad topics such as OR, NCDs and equity. 
The scoping review followed Preferred Reporting Items 
for Systematic Reviews and Meta- Analyses (PRISMA) 
guidelines for scoping reviews26 and was registered on 
PROSPERO reference CRD42018096803.
search strategy
Web of Science, Scopus, Embase and MEDLINE were 
searched to cover both health and social science. Free- 
text searches were undertaken for Web of Science and 
Scopus. Free text plus Emtree and MESH subject head-
ings were used for Embase and MEDLINE, respectively. 
The database free- text search strategy drew on the work of 
Bradley et al,17 which searched papers published between 
2000 and 2014 at the intersection of four domains: oper-
ational research, LMICs, health and decision- making/
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policy- making. To these a fifth domain was added for 
NCDs. The current search included papers published 
between 1 January 2015 and 10 May 2018. An English 
language filter was applied to all results. Full search strat-
egies are included in online supplementary appendix 1.
study inclusion
Two researchers (NG and JK) independently sifted all arti-
cles, first according to title and abstract and second using 
the full text. The inclusion criteria drew on those used by 
Bradley et al17 with the additional specification of NCDs.
The first criteria was for the study to use OR methods, 
including: optimisation models (eg, linear and non- linear 
programming, goal programming, location allocation 
models); simulation models (eg, discrete event, agent- 
based); dynamic state transition models (eg, Markov tran-
sition) and static cohort- level models (eg, decision tree 
model).
Second, the study must explore a decision- making/
policy- making problem compatible with OR. This could 
be: several competing interventions or policy options are 
compared to propose the best/optimal strategy (including 
comparing current status quo vs a new option); outcomes 
are modelled for competing intervention or policy 
scenarios/options, including disease burden, budget 
impact and cost- effectiveness; issues of logistics, supply 
chain, distribution, scheduling are explored, including 
studies that highlight operational inefficiencies or poor 
performance; what if scenarios are tested (eg, what if 
cancer screening coverage was increased).
Third, the study explores an OR problem with a health 
or healthcare focus. This can include public or popula-
tion health (eg, public policy affecting population health, 
mass screening for disease diagnosis and treatment, rela-
tive cost- effectiveness of two or more healthcare interven-
tions) and/or healthcare delivery (eg, efficiency, efficacy 
and cost of delivering given healthcare service).
Fourth, the study focuses on a low- income or middle- 
income setting, either specific country or within- country 
or supranational region.
Finally, the study must focus on an NCD. The list of 
NCDs was taken from the WHO Global Health Estimates3 
and Global Burden of Disease project.1 Conditions which 
are not categorised as NCDs but have substantial impact 
on the NCD burden were also included. For example, 
human papillomavirus infection and nutritional defi-
ciencies are important causes of cervical cancer and 
increased cardiovascular risk, respectively. Further detail 
is included in online supplementary appendix 1.
At the end of each screening stage, the researchers met 
to compare results and resolve decision discrepancies. 
Ambiguous cases were arbitrated by the other authors 
(JB and PD).
data extraction
Standard bibliographic information was extracted along-
side data for the following topics: geographic coverage, 
policy area, disease/risk area and equity consideration.
narrative synthesis
We conducted a narrative synthesis of study characteris-
tics with a special focus on two themes, namely: (i) appli-
cation area of policy/intervention and (ii) equity consid-
eration adopted by the study (if any). Both of these were 
further broken down and/or categorised as follows:
Policy/Intervention application area
Given the variety of global health solutions (ranging from 
national fiscal policies to individual- level healthcare), 
studies were inductively categorised into the following 
application areas, which arose through reviewing of the 
papers:
A. Public health policy: policy working via a non- healthcare 
mechanism to modify key risk factors for NCDs; ex-
amples include taxation of sugar- sweetened beverages 
and regulations to create smoke- free areas.
B. Population screening: screening of general populations 
at risk of a specific NCD before provision of relevant 
healthcare to diagnosed persons; examples include 
national cervical cancer screening programmes and 
diabetes screening in primary care.
C. Healthcare provision
1. Access: provision of healthcare to defined patient 
groups who previously had no access to a compara-
ble standard of care; examples include charitable 
provision of surgery to patients with cancer who 
otherwise have no access to oncology treatment 
and provision of dialysis to patients with end- stage 
renal disease who otherwise would have received 
basic supportive care only.
2. Comparative: effectiveness and/or cost- effectiveness 
studies of two or more alternative healthcare in-
terventions of comparable standards for a defined 
patient group; examples include comparison of 
two chemotherapy regimens for patients with 
breast cancer and comparison of two insulin- based 
treatments for patients with diabetes to achieve su-
perior control of given disease and/or lower inter-
vention cost.
Within each application area, the included studies were 
further grouped by risk area (for studies under category 
A) or targeted disease area (for studies under categories 
B and C). Application areas were mutually exclusive.
Equity consideration
Studies were categorised by whether and how they 
demonstrated a concern for equity, this categorisation 
was inductive:
I. Differential subgroup impact: the study evaluates the 
differential impact of intervention outcomes on 
population subgroups delineated by social, econom-
ic, demographic and geographic or any other pre-
disposing environmental factor beyond individual 
control. The outcomes may include health (eg, life 
expectancy, disability- adjusted life years (DALY)), 
healthcare access or financial risk protection from 
NCD- induced healthcare expenditure.
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Figure 1 Preferred Reporting Items for Systematic Reviews and Meta- Analyses (PRISMA) low chart. LMIC, low- income and 
middle- income countries; NCD, non- communicable disease; OR, operational research.
II. Disadvantaged group targeting: the intervention tar-
gets healthcare access and/or health improvement 
in a population group deemed to be socially disad-
vantaged; examples of such groups include women, 
infants and children, the elderly and rural popula-
tions.
III. Universal coverage of healthcare: the intervention aims 
to expand access to preventive or treatment services.
i. Preventive services: widening the provision of pre-
ventative healthcare. For example, a new nation-
al cancer screening programme is compared 
with no screening or opportunistic screening at 
healthcare centres, or where coverage levels are 
varied and evaluated within the study.
ii. Treatment services: provision of clinical care to 
patients who previously had no access. We only 
include cases representing an improvement 
in coverage of public sector healthcare, that is, 
where the cost of relevant healthcare is at least 
partly borne by the government.
Studies under category (I) must explicitly highlight 
differential impact as an equity concern: simple stratifi-
cation of results (eg, by age or sex) with no discussion 
of equity was deemed insufficient for inclusion. These 
equity categories are not mutually exclusive and a study 
was able to fall into multiple categories.
Patient and public involvement
As this paper is a scoping review comprising an assess-
ment of the academic literature, there was no direct 
patient and public engagement on the paper.
resulTs
database search and study inclusion
The PRISMA flow diagram illustrates the search process, 
including article screening and study inclusion (figure 1). 
The database search resulted in 3055 papers after dupli-
cates were removed. After screening by title and abstract, 
269 papers remained for the full- text sift. An additional 
134 papers were excluded at this stage and 14 articles 
were added via searching of previous reviews and refer-
ence chasing. This resulted in a final group of 149 articles 
for data extraction.
study characteristics
There were 29 (19%) studies evaluating public health poli-
cies working via non- healthcare mechanisms to reduce 
key modifiable risk factors for NCDs and 30 (20%) that 
evaluated population screening interventions. Of the 90 
(60%) studies that evaluated healthcare provision for 
defined patient groups, 41 were primarily concerned with 
providing access to new or higher- standard healthcare, 
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Figure 2 (A) Number of studies by application area, grouped according to income classiication (multiple income category 
denotes studies including more than one country spanning more than one income classiication). (B) geographical location of 
the target population. LMIC, low- income and middle- income countries.
while 49 included evaluation of strategies with a compar-
ative standard of care. When classified by application area 
and income group of the country/countries included 
in the study, a very high proportion, 76% and 85%, of 
public health policy and comparative evaluation studies, 
respectively, incorporated only upper- middle- income 
countries (figure 2A). At the same time, few papers from 
across any application area included countries from 
multiple income categories. The papers covered a broad 
range of countries, the highest number of papers (47, 
32%) address the Chinese context, followed by Thailand 
and Mexico each with 12 papers (8%) (figure 2B). The 
authors affiliated with institutions in high- income coun-
tries (HICs) were listed in 68% of the papers, while 15% 
of the papers did not include any author from the country 
studied. The authors affiliated with governmental depart-
ments, quasi- governmental institutions or specific hospi-
tals in the country of interest were included in 44% of 
the papers.
Policy/Intervention application area
The 149 included studies covered a broad range of risk 
factors and disease areas (figure 3). Neoplasms consti-
tute a relatively large group across population screening, 
healthcare access and comparative studies. Cardiovas-
cular disease and diabetes and kidney disease are also a 
strong focus. The risk factors with the greatest proportion 
of papers relate to dietary risks and tobacco, which link 
strongly to the aforementioned disease areas. A summary 
table referencing every included study and an expanded 
table detailing policy/intervention and comparator, 
equity consideration, and base- case evaluation results are 
included in online supplementary appendix 2, tables A 
and B.
When the proportion of NCD burden across LMICs, 
using Global Burden of Disease data,1 was compared with 
the proportion of papers in the review, the results showed 
that OR methods have been used across all NCD categories, 
with the exception of neurological disorders (figure 4). 
The greatest proportion of papers address neoplasms; 
these include a number of comparative studies which 
compare cancer drug A versus drug B and a number of 
screening programmes mainly focused on cervical cancer. 
Diabetes and kidney diseases and substance use disorders 
are also over- represented within the search results with a 
number of public health policies focused on tobacco and 
alcohol. Neurological disorders are unrepresented.
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Figure 3 Disease/Risk type by application area. Public health papers categorised by risk factor, all others by disease area. 
Colours are not meaningful. Public health policies covering more than one risk area were counted in multiple categories.
Figure 4 Comparison of reported disease burden as measured by disability- adjusted life years (DALYs) and number of 
publications. Multiple categories for each paper let the paper count in multiple categories.
Equity consideration
Of the 149 papers, 88 (59%) fell into at least one of the 
three equity categories (figure 5).
Differential subgroup impact
The eight subgroup impact papers mainly comprised 
extended cost- effectiveness analysis (ECEA) (n=7). ECEA 
requires the inclusion of OOP expenditure and at least 
one measure of financial risk protection, providing an 
explicit link between health and poverty (catastrophic 
health expenditure, cases of poverty averted, value of 
insurance).27 These measures, along with health outcome 
measures, are reported by income or wealth quin-
tiles. Wealth quintiles are calculated using a composite 
measure of household asset ownership (eg, TV, fridge, 
etc) and access to amenities (eg, water and sanitation). 
Wealth quintiles were used in studies on Ethiopia (n=2), 
Uganda (n=1) and India (n=1); income quintiles were 
used in China (n=2) and South Africa (n=1). A range of 
health outcomes were reported including deaths averted 
(n=4), life years gained (n=1), DALYs (n=1) and health- 
adjusted life years gained (n=1). The only study demon-
strating subgroup impact which did not follow an ECEA 
methodology evaluated a sugar- sweetened beverage (SSB) 
tax in Mexico reporting the health outcome (percentage 
change in body mass index) by SES (low, medium and 
high), age and sex.
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Figure 5 Equity categorisation. *The sum of the totals is 
>149 as a number of papers are included in more than one 
equity category. †The sum of disadvantaged groups is >47 
as a number of papers cover more than one disadvantaged 
group. ‡The sum of treatment and preventions services 
is >68 as four papers cover both. LMIC, low- income and 
middle- income countries; NCD, non- communicable disease.
Disadvantaged group targeting
A total of 47 papers evaluated policies specifically 
targeted at socially disadvantaged groups. The most 
populous group was women (n=28), followed by neonates 
(n=9), children (n=9), rural dwellers (n=3), older adults 
(n=2) and economically disadvantaged (n=1). Four of 
the papers concerned the intersection of two groups, 
including rural and neonatal (n=2), rural and women 
(n=1) and women and neonatal (n=1).
Universal health coverage
All 41 of the healthcare provision access papers fell into 
this category as did an additional 4 comparative papers 
which examined different funding strategies and 23 of 
the population screening papers, totalling 68. Screening 
papers which did not fall into this category were either 
concerned with the cost- effectiveness of comparable 
screening strategies (n=4), budget distribution between 
screening and treatment (n=1) or were paid for exclu-
sively by private insurance (n=1).
Papers demonstrating an equity focus including different 
approaches to equity, according to policy/intervention application 
area
The intersection between application area and equity 
approach taken is included in online supplementary 
appendix 2, table C. In summary, of the public health 
papers, seven (24%) incorporated equity, three via the 
demonstration of equity impact (two were ECEAs and 
one stratified outcomes by SES, sex and age) and four via 
a focus on disadvantaged groups, namely children (n=2), 
neonates (n=1) and women and neonates combined 
(n=1).
Population screening demonstrated concern for equity 
in 29 papers (97%) mainly via a focus on disadvantaged 
groups, of which the majority were women (n=15), and 
extending preventative healthcare services via universal 
provision of screening policies. The screening interven-
tions were dominated by cervical cancer (n=8), congen-
ital disease (n=6) and breast cancer (n=4).
All 41 healthcare provision access studies by defini-
tion fell into the universal health coverage, however, 
many papers also fell into the other equity categories. 
Four papers used ECEA to demonstrate the impact of 
the healthcare treatment by income/wealth quintiles 
including charitable surgery in Uganda, epilepsy treat-
ment in India, mental health treatment in Ethiopia and 
a package of diverse healthcare treatments in Ethiopia. 
There was also range of disadvantaged groups covered 
across 12 of the papers including children (n=5), women 
(n=4), the elderly (n=1), neonates (n=1) and lower socio-
economic groups (n=1).
The healthcare provision comparative studies had the 
lowest percentage of papers considering equity with just 
11 (23%). Eight covered disadvantaged groups, including 
women (n=6) and children (n=2). The four papers in 
this application area which evaluated alternative cancer 
treatments demonstrated concern for universal coverage 
by incorporating scenarios involving different levels of 
public funding for the treatment.
dIsCussIon
The range of studies using quantitative OR methods 
(broadly understood) demonstrates the breadth of 
public health and clinical interventions available to poli-
cymakers for addressing the burden of NCDs in LMICs. 
The much greater number of OR studies evaluating 
NCD interventions included in this review, compared 
with previous reviews,17 23 suggests that researchers have 
responded to previous conclusions which highlighted 
the gap in NCD research in LMICs. However, the focus of 
the published studies was not proportional to the disease 
burden reported by the Global Burden of Disease Study 
for LMICs. The disproportionate focus on cancers may 
reflect an international funder- driven agenda which 
supports cancer screening programmes for women 
and girls.28 29 The large number of papers relating to 
substance use, including tobacco and alcohol papers, 
may also reflect influence of the WHO’s Framework 
Convention on Tobacco Control and global reporting 
of alcohol harm.30 31 The topics of published papers also 
mirror the primarily Northern- based study funding and 
a research agenda influenced by HIC research partners 
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(68% of papers listed authors affiliated to institutions in 
HICs).
Equity was considered in 59% of the 149 papers 
included in the review. This supports the renewed focus 
on health equity as it relates to differential impact between 
subpopulations, targeting of disadvantaged groups and 
extending universal healthcare. In a previous scoping 
review of OR studies only 4% of studies included an 
equity consideration and these studies focused primarily 
on access to healthcare.17 Although their review differed 
from ours, it seems plausible that operational researchers 
are responding to the increasing global focus on equity, 
evident in the SDGs.
Despite this strong focus on equity only eight papers 
explored differential impact, seven of which used extended 
cost- effectiveness analysis. These papers, across all three 
application areas, demonstrate the prominence of ECEA 
as a methodological approach and its flexibility of applica-
tion to diverse health interventions. However, a number of 
papers which modelled universal upstream public health 
interventions did not incorporate a concern for differen-
tial impact, including SSB taxes, unhealthy goods taxes 
and salt reduction policies,11 13 32–35 acknowledged in the 
papers as a key limitation. Given the importance of these 
upstream policies in reducing risk factors for NCDs, often 
making use of fiscal measures which are likely to impact 
the poor more severely than the rich, the lack of consider-
ation of differential impact is a clear weakness.
The finding that 44% of papers included authors affili-
ated with governmental departments, quasi- governmental 
institutions or specific hospitals in the country of interest 
infers a degree of stakeholder engagement in OR. 
However, it should be noted that 15% of papers had no 
author at all from the country of study so there is still 
significant progress to be made in embedding research 
in its local context.
We argue that OR shows much potential to improve 
the quality of decision- making and guide improvements 
in population health and equity. Researchers should 
attempt to incorporate differential impact within their 
research wherever possible, although we acknowledge 
that barriers exist, including data availability, capacity 
constraints and researcher familiarity with methods. 
Understanding which groups are of interest, or indeed 
which intersectionalities (eg, women and rural), is critical 
to the pursuit of equity and is highly context- dependent. 
Closer collaboration between researchers and decision 
makers and implementers would enable a deeper and 
more nuanced understanding of the equity impact of the 
policy and its implementation.
Greater stakeholder engagement would also strengthen 
the development and validation of models, and the 
translation of findings into policy and practice. Further 
research into the embeddedness of OR research in local 
decision- making processes would provide greater insight 
into the role that local stakeholders play in setting the 
research agenda as well as in the research process itself 
and in uptake of key findings.
To the best of our knowledge, this scoping review is the 
most comprehensive one to date covering all approaches 
to reduce NCD burden and promote health and health-
care equity in the SDG era. However, there are several 
limitations to this research, which in part reflect the 
nature of a scoping review. Databases were chosen to 
cover medicine and social science, but engineering data-
bases may have provided additional papers. The search 
period was deliberately designed to provide a cross- 
sectional snapshot of the SDG era (2015–2018), however 
this prevents the consideration of OR applications before 
this period and of trends over time. Important studies may 
have been missed due to date range alone, for example, 
those evaluating excise tax on SSB in India33 and South 
Africa.11 The limitation to English language papers may 
have biassed the results, in particular the conclusion that 
most research has been completed in HICs. There was 
no formal quality assessment for included studies due to 
the very diverse nature of their aims and methods. There 
was also limited discussion on the technical aspects of OR 
models due to our focus on setting, application areas and 
equity categories in this manuscript.
In summary, this review found that OR is being used to 
evaluate a broad range of policies across a range of NCDs 
in LMICs, although the focus of the papers was dispro-
portionate to the relative disease burden in these coun-
tries. A majority of papers incorporated a concern for 
equity, although this is primarily through targeted poli-
cies and expansion of healthcare. The included papers 
demonstrated that OR methods can be used to illustrate 
differential impact, highlighting vulnerable groups, 
across a range of application areas and disease types. This 
however, appears to currently be an underused approach 
in relation to OR on NCD policy in LMICs.
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